Gyre Therapeutics, Inc. Receivables, Net, Current
Gyre Therapeutics, Inc. (GYRE) had Receivables, Net, Current of $10.00 thousand as of 2015-06-30, per its 10-Q filed 2015-07-31.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2015-07-31
- 2015-06-30: Receivables, Net, Current $10.00K.
- 2015-03-31: Receivables, Net, Current $68.00K.
- 2014-12-31: Receivables, Net, Current $141.00K.
- 2014-09-30: Receivables, Net, Current $57.00K.
| Period end | Receivables, Net, Current |
|---|---|
| 2015-06-30 | $10.00K 10-Q · filed 2015-07-31 |
| 2015-03-31 | $68.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $141.00K 10-Q · filed 2015-07-31 |
| 2014-09-30 | $57.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $28.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $343.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $278.00K 10-K · filed 2015-03-16 |
| 2012-12-31 | $1.38M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |